Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2012
10/18/2012US20120263731 HIGH CONCENTRATION ANTI-TNFalpha ANTIBODY LIQUID FORMULATIONS
10/18/2012US20120263702 Human Aminoacyl-tRNA Synthetase Polypeptides Useful For The Regulation of Angiogenesis
10/18/2012US20120263695 Composition having strains of lactobacillus fermentum
10/18/2012US20120263675 Bivalent diazo bicyclic smac
10/18/2012CA2832953A1 Compositions and methods for the treatment of nasal conditions
10/18/2012CA2832886A1 Polymer conjugated prostaglandin analogues
10/18/2012CA2830896A1 Aqueous ophthalmic composition
10/17/2012EP2511268A1 Oxazine derivative
10/17/2012EP2510927A2 Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage
10/17/2012EP2510098A1 Methods and compositions for treating diseases, disorders or injury of the cns
10/17/2012EP2509633A2 Nanoparticle carrier systems based on poly(dl-lactic-co-glycolic acid) (plga) for photodynamic therapy (pdt)
10/17/2012EP2509628A2 Sr-bi as a predictor of human female infertility and responsiveness to treatment
10/17/2012EP2509596A2 Compounds and methods of treating ocular disorders
10/17/2012EP2509582A1 Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof
10/17/2012CN1922171B Pyrimidine derivative
10/17/2012CN102741272A Peptides inhibiting adhesion of aspergillus fumigatus to cornea
10/17/2012CN102740892A Nanoparticle carrier systems based on poly(DL-lactic-co-glycolic acid) (PLGA) for photodynamic therapy (PDT)
10/17/2012CN102740860A Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases
10/17/2012CN102740830A Sustained release delivery devices
10/17/2012CN102731658A Tat PTD-Endostatin recombination protein, preparation method and application thereof
10/17/2012CN102731499A Lactam compounds and their use as pharmaceuticals
10/17/2012CN102731413A Urea compound and its preparation method, intermediate and use
10/17/2012CN102727874A Recombinant hirudin eye drops and preparation method thereof
10/17/2012CN102727840A Huolong Dan
10/17/2012CN102727729A Decoction for treating eye disease
10/17/2012CN102727718A Traditional Chinese medicine for treatment of nerve deafness and tinnitus
10/17/2012CN102727668A Chinese medicine composition with effect of alleviating asthenopia and preparation method thereof
10/17/2012CN102727568A Traditional Chinese medicinal feedstock composition for removing liver fire, improving eyesight and mainly treating senile hyperopia and preparation method thereof
10/17/2012CN102727513A Small RNAs targeting tissue factor (TF) gene and use thereof
10/17/2012CN102727501A Uses of sapogenins and their derivatives
10/17/2012CN102727482A Daidzein-hydroxypropyl-beta-cyclodextrin clathrate and its preparation method
10/17/2012CN102727425A Nitroimidazole oculentum and preparation method thereof
10/17/2012CN102727423A Betaxolol hydrochloride ion-sensitive eye-use in-situ gel and preparation method thereof
10/17/2012CN102274242B Traditional Chinese medicine formula for treating eye disease and manufacturing method thereof
10/17/2012CN102046166B Methods of treating dry eye
10/17/2012CN101987163B Medicine for treating cataract and preparation method thereof
10/17/2012CN101972470B In-situ gel composition for eyes
10/17/2012CN101851237B spiro compounds, method for preparing same and application thereof
10/16/2012US8288537 Caspase inhibitors and uses thereof
10/16/2012US8288380 Thiophenediamine derivative having urea structure
10/16/2012US8287873 Vascular endothelial cell growth factor antagonists and uses thereof
10/16/2012CA2685230C Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
10/16/2012CA2466773C Inhibitor oligonucleotides and their use for specific repression of a gene
10/11/2012WO2012139132A1 Methods and compositions to promote ocular health
10/11/2012WO2012139069A2 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
10/11/2012WO2012138879A2 Peptides for the treatment of hearing
10/11/2012WO2012137987A1 Method for treating asthenopia
10/11/2012WO2012137610A1 Pharmaceutical preparation
10/11/2012WO2012106118A3 Method of making ophthalmic devices and components thereof from hydrophobic acrylic (ha) polymers with reduced or eliminated glistenings
10/11/2012WO2012091449A3 Pharmaceutical composition comprising phosphorylated grasp for treating cystic fibrosis
10/11/2012WO2012083195A3 Magnetic control of eyelid position
10/11/2012US20120259008 Method for treating asthenopia
10/11/2012US20120258997 New application of 2-pyrrolidone derivatives
10/11/2012US20120258987 Lysophosphatidic acid receptor antagonists
10/11/2012US20120258959 Pyridone gpr119 g protein-coupled receptor agonists
10/11/2012US20120258921 Peptides for the treatment of hearing
10/11/2012US20120258916 Ophthalmic preparations based on bdnf (brain-derived neurotrophic factor) and their use
10/11/2012US20120258176 Nanoparticles for protein drug delivery
10/11/2012US20120258170 Pharmaceutical co-crystals of quercetin
10/11/2012US20120258168 Methods and compositions to promote ocular health
10/11/2012US20120258163 Tyrosine Kinase Microspheres
10/11/2012US20120258147 Method for inhibiting angiogenesis
10/11/2012US20120258114 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
10/11/2012US20120258080 Pyridopyrazine derivatives and their use
10/11/2012US20120258041 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
10/11/2012CA2832303A1 Pharmaceutical preparation
10/11/2012CA2832106A1 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
10/11/2012CA2830626A1 Method for treating asthenopia
10/10/2012EP2508513A1 2-pyridone compounds
10/10/2012EP2508183A1 Interleukin-1 blocker for use in the treatment of age-related macular degeneration
10/10/2012EP2508182A1 Hydralazine for use in the treatment of age-related macular degeneration
10/10/2012EP2507241A1 Methanocarba adenosine derivatives and dendrimer conjugates thereof
10/10/2012EP2506851A1 Use of a dipyridyl compound for treating rosacea
10/10/2012EP2506843A2 Treating xerophthalmia with compounds increasing meibomian gland secretion
10/10/2012EP2506831A2 Carboxyvinyl polymer-containing nanoparticle suspension
10/10/2012CN1607957B Modulation of excitable tissue function by peripherally administered erythropoietin
10/10/2012CN102724965A Carboxyvinyl polymer-containing nanoparticle suspensions
10/10/2012CN102718867A Polypeptide compound for inhibiting angiogenesis and tumor growth
10/10/2012CN102718710A Morphinan compounds
10/10/2012CN102716464A Application of oligopeptide to preparation of medicine for treating angiogenesis ophthalmic diseases
10/10/2012CN102716352A Eyesight-improving traditional Chinese medicine
10/10/2012CN102716322A Ping xiao eyesight protection pill and its preparation method
10/10/2012CN102716278A Eye ointment for improving eyesight
10/10/2012CN102716152A Method for processing horn-type medicinal materials
10/10/2012CN102716117A Application of naringenin in preparing medicines for resisting apoptosis of retinal photoreceptor cell
10/10/2012CN102716079A Pirenoxine-containing suspension-type aqueous preparation
10/10/2012CN102716077A Sitafloxacin auristilla and preparation method thereof
10/10/2012CN102716074A Bimatoprost eye drops and preparation method thereof
10/10/2012CN102715308A Tea preparation method
10/10/2012CN102276683B Smilaxchinoside compound
10/10/2012CN102008488B Triamcinolone acetonide ophthalmic preparation and preparation method thereof
10/10/2012CN101987847B Novel heterocyclic NF-kB inhibitors
10/10/2012CN101868251B Pharmaceutical containing HIF-1alpha alpha and HIF-2alpha alpha expression inhibitor
10/10/2012CN101854943B Grifola frondosa extract and composition containing the same for promoting the production of hyaluronic acid (hyaluronan)
10/10/2012CN101605531B Ophthalmic compositions containing a synergistic combination of three polymers
10/10/2012CN101528211B Ophthalmic percutaneous absorption type preparation
10/10/2012CN101450934B Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/10/2012CN101052305B Isolated lineage negative hematopoietic stem cells and methods of treatment therewith
10/09/2012US8283363 Carboxamide compounds and their use as calpain inhibitors
10/09/2012US8283323 Withanolide compounds as inhibitors of fibrosis and identification of molecular targets for anti-fibrotic drug development
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 531